These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29406938)

  • 1. Metabolic Syndrome: Systems Thinking in Heart Disease.
    Dommermuth R; Ewing K
    Prim Care; 2018 Mar; 45(1):109-129. PubMed ID: 29406938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelationships with Metabolic Syndrome, Obesity and Cardiovascular Risk.
    Said S; Mukherjee D; Whayne TF
    Curr Vasc Pharmacol; 2016; 14(5):415-425. PubMed ID: 27456105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome and non-cardiac vascular diseases: an update from human studies.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Pharm Des; 2014; 20(31):4944-52. PubMed ID: 24320038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach.
    Santilli F; D'Ardes D; Guagnano MT; Davi G
    Curr Med Chem; 2017; 24(24):2602-2627. PubMed ID: 28699503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified screening and treatment of the metabolic syndrome for cardiovascular risk reduction.
    Wong ND
    Prev Cardiol; 2005; 8(1):47-52; quiz 53-4. PubMed ID: 15722694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview.
    Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Vasc Pharmacol; 2014; 12(4):627-41. PubMed ID: 23627982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis, prevention, and intervention for the metabolic syndrome.
    Scott CL
    Am J Cardiol; 2003 Jul; 92(1A):35i-42i. PubMed ID: 12867253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome.
    Cornier MA; Dabelea D; Hernandez TL; Lindstrom RC; Steig AJ; Stob NR; Van Pelt RE; Wang H; Eckel RH
    Endocr Rev; 2008 Dec; 29(7):777-822. PubMed ID: 18971485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A constellation of complications: the metabolic syndrome.
    Grundy SM
    Clin Cornerstone; 2005; 7(2-3):36-45. PubMed ID: 16473259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of the metabolic syndrome.
    McCracken E; Monaghan M; Sreenivasan S
    Clin Dermatol; 2018; 36(1):14-20. PubMed ID: 29241747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds.
    Rochlani Y; Pothineni NV; Kovelamudi S; Mehta JL
    Ther Adv Cardiovasc Dis; 2017 Aug; 11(8):215-225. PubMed ID: 28639538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism.
    Dwyer AA; Quinton R
    Front Horm Res; 2018; 49():156-169. PubMed ID: 29895006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Historical perspectives of the metabolic syndrome.
    Oda E
    Clin Dermatol; 2018; 36(1):3-8. PubMed ID: 29241750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome, autoimmunity and rheumatic diseases.
    Medina G; Vera-Lastra O; Peralta-Amaro AL; Jiménez-Arellano MP; Saavedra MA; Cruz-Domínguez MP; Jara LJ
    Pharmacol Res; 2018 Jul; 133():277-288. PubMed ID: 29382608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
    Fahed G; Aoun L; Bou Zerdan M; Allam S; Bou Zerdan M; Bouferraa Y; Assi HI
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association.
    Bozkurt B; Aguilar D; Deswal A; Dunbar SB; Francis GS; Horwich T; Jessup M; Kosiborod M; Pritchett AM; Ramasubbu K; Rosendorff C; Yancy C;
    Circulation; 2016 Dec; 134(23):e535-e578. PubMed ID: 27799274
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic Syndrome as a Multifaceted Risk Factor for Oxidative Stress.
    Spahis S; Borys JM; Levy E
    Antioxid Redox Signal; 2017 Mar; 26(9):445-461. PubMed ID: 27302002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome and cardiometabolic risk: scope of the problem and current standard of care.
    Lender D; Sysko SK
    Pharmacotherapy; 2006 May; 26(5 Pt 2):3S-12S. PubMed ID: 16637782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Influence of Epicardial Fat and Nonalcoholic Fatty Liver Disease on Heart Rate Recovery in Metabolic Syndrome.
    Cho KI; Jo EA; Cho SH; Kim BH
    Metab Syndr Relat Disord; 2017 Jun; 15(5):226-232. PubMed ID: 28346857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.